抗结核天然产品Evybactinin的总合成和结构重新分配
Vladyslav Lysenko1, Sangkeun Son2, Monique E Theriault2
1Biological Chemistry Group, Institute of Biology, Leiden University, Leiden, The Netherlands.
Chemistry (Weinheim an der Bergstrasse, Germany)
|October 16, 2024
概括
研究人员首次实现了针对M.结核病的强效抗生素evibactin的总合成. 这项研究修订了evybactin.
科学领域:
- 药用化学 医学化学
- 有机合成 有机合成
- 微生物学 微生物学
背景情况:
- 抗生素耐药性是一个日益严重的全球健康危机,需要开发新型抗菌剂.
- 埃维巴克是一种非核糖体脱皮,对Mycobacterium tuberculosis的生长有选择性和强烈的抑制作用.
研究的目的:
- 为了实现天然产品evybactin的第一个完整合成.
- 修订和确认evybactin的结构配置.
- 开发一种可扩展的合成途径,以生产大量的evybactin.
主要方法:
- 使用固相方法,对evibactin的总合成.
- 通过分析技术进行结构阐明和确认.
- 为大规模生产优化合成协议.
主要成果:
- 成功完成了埃维巴克的总合成.
- 在宏观周期内从L-到D-配置中对3-甲基希斯提丁残留物立体化学的校正.
- 开发一种优化的固体相路径,产生数百毫克的数量.
结论:
- 经过总合成,已经证实了Evibactin的修订结构.
- 一种可扩展的合成方法为进一步的药理评估提供了足够的evibactin.
- 埃维巴克仍然是抗击结核病的有希望的候选药物.
更多相关视频
09:08From a Natural Product to Its Biosynthetic Gene Cluster: A Demonstration Using Polyketomycin from Streptomyces diastatochromogenes Tü6028
Published on: January 13, 2017
17.1K
07:50Author Spotlight: Scalable Drug Screening Protocol for Efficient Discovery of M. abscessus Treatments
Published on: October 25, 2024
1.6K
相关概念视频
Biosynthesis in Bacteria
Biosynthesis in bacteria is a fundamental anabolic process that generates essential macromolecules, including proteins, nucleic acids, lipids, and polysaccharides. These macromolecules are critical for cellular growth, replication, and function. The process is tightly regulated and energetically linked to catabolic pathways to ensure optimal resource utilization.Biosynthetic pathways begin with precursor metabolites such as pyruvate, acetyl-CoA, and glucose-6-phosphate derived from glycolysis,...
Production of Antibiotics
Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...
Production of Pharmaceuticals
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under sterile, tightly...
Inhibitors of Gram-positive Cell Wall Synthesis
Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Inhibitors of Bacterial Protein Synthesis
Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Inhibitors of Bacterial DNA Synthesis
Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
